- Home
- AVB vs LH Comparison
AVB vs LH Comparison
Compare AVB & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVB | LH |
|---|---|---|
| Founded | 1978 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7B | 21.0B |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AVB | LH |
|---|---|---|
| Price | $191.76 | $277.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 9 |
| Target Price | $198.40 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 961.1K | 582.5K |
| Earning Date | 04-27-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.86% | 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | 2.33 | ★ 3.35 |
| Revenue | $3,040,725,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | $4.04 | $8.26 |
| Revenue Next Year | $5.03 | $4.81 |
| P/E Ratio | ★ $82.36 | $82.63 |
| Revenue Growth | 4.36 | ★ 7.25 |
| 52 Week Low | $160.10 | $241.81 |
| 52 Week High | $205.00 | $293.72 |
Technical Indicators
Market Signals| Indicator | AVB | LH |
|---|---|---|
| Relative Strength Index (RSI) | 56.06 | 57.78 |
| Support Level | $174.68 | $260.01 |
| Resistance Level | N/A | $292.13 |
| Average True Range (ATR) | 3.48 | 6.12 |
| MACD | 0.25 | 0.46 |
| Stochastic Oscillator | 67.00 | 62.90 |
Price Performance
Historical ComparisonAbout AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 296 apartment communities with more than 90,000 units and is developing 24 additional properties with approximately 8,600 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.